We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$169B
Turnover
4.85%
1-Year Est. Return
114.72%
This Fund
S&P 500
This Quarter
Est. Return
+8.4%
1 Year Est. Return
+114.72%
3 Year Est. Return
+234.44%
5 Year Est. Return
+291.25%
10 Year Est. Return
+1,263.36%
AUM
$149B
AUM Growth
+$5.43B
(+3.8%)
Cap. Flow
-$4.27B
Cap. Flow
% of AUM
-2.87%
Top 10 Holdings %
Top 10 Hldgs %
30.32%
Holding
338
New
11
Increased
51
Reduced
229
Closed
5
Avg Time Held
4.7
years
Top 10 Avg Time Held
5
years
Top 20 Avg Time Held
4.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Splunk Inc
SPLK
|
+$151M |
| 2 |
Alibaba
BABA
|
+$115M |
| 3 |
XPeng
XPEV
|
+$79M |
| 4 |
Raymond James Financial
RJF
|
+$71.4M |
| 5 |
Allogene Therapeutics
ALLO
|
+$64.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$285M |
| 2 |
NetApp
NTAP
|
+$236M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$220M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$209M |
| 5 |
Adobe
ADBE
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.47% |
| 2 | Healthcare | 26.99% |
| 3 | Industrials | 12.32% |
| 4 | Consumer Discretionary | 10.96% |
| 5 | Financials | 10.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
226
nVent Electric
NVT
$23.2B
| $27.7M | 0.02% |
887,900
| – | – |
2018 Q2
12 quarters
|
|
227
LPL Financial
LPLA
$25.3B
| $27.5M | 0.02% |
204,000
| – | – |
2020 Q1
5 quarters
|
|
228
Comscore
SCOR
$53.1M
| $27.3M | 0.02% |
273,352
-1,046
| -0.4% | -$82K |
2013 Q2
32 quarters
|
|
229
Kirby Corp
KEX
$7.16B
| $27.3M | 0.02% |
450,100
| – | – |
2020 Q4
2 quarters
|
|
230
BridgeBio Pharma
BBIO
$13B
| $27.2M | 0.02% |
446,860
+91,623
| +26% | +$5.23M |
2021 Q1
1 quarter
|
|
|
NUVA
231
DELISTED
NuVasive, Inc.
NUVA
| $26.4M | 0.02% |
388,800
-10,200
| -3% | -$696K |
2013 Q2
32 quarters
|
|
232
Xometry
XMTR
$5.2B
| $26.2M | 0.02% |
+300,000
| New | +$26.2M |
2021 Q2
0 quarters
|
|
233
Ulta Beauty
ULTA
$25.3B
| $26M | 0.02% |
75,300
| – | – |
2017 Q4
14 quarters
|
|
234
Matsons
MATX
$6.97B
| $25M | 0.02% |
390,592
-1,700
| -0.4% | -$111K |
2019 Q3
7 quarters
|
|
235
NN Inc
NNBR
$320M
| $24.8M | 0.02% |
3,376,100
-1,678,591
| -33% | -$12.6M |
2014 Q1
29 quarters
|
|
236
American Homes 4 Rent
AMH
$11.2B
| $24.6M | 0.02% |
633,550
-235,650
| -27% | -$8.74M |
2020 Q2
4 quarters
|
|
237
GSK
GSK
$99.4B
| $22M | 0.01% |
441,120
-6,320
| -1% | -$304K |
2013 Q2
32 quarters
|
|
238
Brinker International
EAT
$8.5B
| $21.7M | 0.01% |
+351,200
| New | +$22.2M |
2021 Q2
0 quarters
|
|
|
CALA
239
DELISTED
Calithera Biosciences, Inc
CALA
| $21.6M | 0.01% |
517,185
+500
| +0.1% | +$22K |
2019 Q4
6 quarters
|
|
240
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $21.6M | 0.01% |
193,200
+19,700
| +11% | +$2.38M |
2020 Q1
5 quarters
|
|
241
Rapid7
RPD
$846M
| $19.4M | 0.01% |
205,400
-1,300
| -0.6% | -$109K |
2019 Q4
6 quarters
|
|
242
DELISTED
Amicus Therapeutics
FOLD
| $17.8M | 0.01% |
1,845,000
-285,000
| -13% | -$2.78M |
2019 Q3
7 quarters
|
|
243
Guardant Health
GH
$21.2B
| $17.5M | 0.01% |
140,952
| – | – |
2020 Q3
3 quarters
|
|
244
Snap
SNAP
$10.3B
| $17.3M | 0.01% |
253,600
| – | – |
2020 Q2
4 quarters
|
|
245
ZoomInfo Technologies
GTM
$1.11B
| $16.9M | 0.01% |
323,839
+4,750
| +1% | +$223K |
2020 Q2
4 quarters
|
|
246
Danaher
DHR
$161B
| $16.6M | 0.01% |
+69,965
| New | +$15.5M |
2021 Q2
0 quarters
|
|
247
Philip Morris
PM
$319B
| $15.4M | 0.01% |
155,000
| – | – |
2017 Q2
16 quarters
|
|
248
Saic
SAIC
$5.57B
| $14.7M | 0.01% |
167,800
| – | – |
2020 Q1
5 quarters
|
|
249
Waters Corp
WAT
$42.6B
| $14.2M | 0.01% |
40,998
| – | – |
2020 Q4
2 quarters
|
|
250
Cameco
CCJ
$35.3B
| $14M | 0.01% |
730,700
-6,000
| -0.8% | -$113K |
2019 Q2
8 quarters
|
|
Similar funds
Primecap Management's Q2 2021 Portfolio in Review
As of Q2 2021, Primecap Management held 338 positions worth $149B, up 3.8% from $143B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Trading was light in Q2 2021: portfolio turnover was 4.7%. Primecap Management opened 11 new positions and exited 5, leaving the 338-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 31% a quarter earlier, followed by Healthcare and Industrials.
- Primecap Management's largest Q2 2021 buy was Xometry: 300,000 shares worth $26.2M.
- Primecap Management added most to Splunk Inc in Q2 2021, an estimated $151M increase.
- Primecap Management's biggest Q2 2021 reduction was Eli Lilly, cutting an estimated $285M.
- Primecap Management fully exited Perspecta Inc. Common Stock in Q2 2021, selling an estimated $16.9M.
- Primecap Management's ten largest holdings make up 30% of its $149B portfolio in Q2 2021.
- Primecap Management opened 11 new positions and closed 5 in Q2 2021.
- Primecap Management's portfolio value rose 3.8% quarter-over-quarter to $149B.
Based on Primecap Management's 13F filing for Q2 2021, filed 10 Aug 2021.